Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 209000-001 | Apr 6, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cadila Pharms Ltd | ACYCLOVIR | acyclovir | CAPSULE;ORAL | 201445-001 | Mar 6, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Glenmark Pharms Sa | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 205510-001 | Jul 31, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |